DKK1 overexpression in lung adenocarcinoma has been reported to promote tumor growth and, interestingly, has been linked to resistance to anti-EGFR therapy [63], allowing speculation on a possible role of DKK1 in EGFR downstream activation. The gene discussed is EGFR; the disease is neoplasm.